19-Iodocholesterol
Names | |
---|---|
IUPAC name
(3S,8S,9S,10S,13R,14S,17R)-10-(iodomethyl)-13-methyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | |
Identifiers | |
37414-03-2 | |
3D model (Jmol) | Interactive image |
ChemSpider | 20086815 |
ECHA InfoCard | 100.048.618 |
PubChem | 21150757 |
| |
| |
Properties | |
C27H45IO | |
Molar mass | 512.56 g·mol−1 |
Pharmacology | |
V09XA02 (WHO) (131I) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
19-Iodocholesterol is a derivative of cholesterol with an iodine atom in the 19-position. When the iodine atom is a radioactive isotope (iodine-125 or iodine-131), it is used as an adrenal cortex radiocontrast agent for in the assessment of patients suspected of having Cushing's syndrome, hyperaldosteronism, pheochromocytoma and adrenal remnants following total adrenalectomy.[1]
References
- ↑ 19-Iodocholesterol (125I), CID 3032874 from PubChem
This article is issued from Wikipedia - version of the 11/30/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.